schizandrin has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, TJ | 1 |
| Chen, HL; Kou, JP; Li, DP; Li, F; Tan, YS; Yan, Y; Yu, BY; Zhai, KF | 1 |
2 other study(ies) available for schizandrin and cardiovascular agents
| Article | Year |
|---|---|
[Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin].
Topics: Animals; Cardiovascular Agents; Cyclooctanes; Doxorubicin; Drugs, Chinese Herbal; Free Radical Scavengers; Leukemia P388; Lignans; Malondialdehyde; Mitochondria, Heart; Phenanthrenes; Polycyclic Compounds | 1991 |
Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis.
Topics: Apoptosis; Cardiovascular Agents; Cell Hypoxia; Cell Survival; Chromatography, High Pressure Liquid; Cyclooctanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; L-Lactate Dehydrogenase; Lignans; Malondialdehyde; Nitric Oxide; Polycyclic Compounds; Reactive Oxygen Species; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |